(PharmaNewsWire.Com, March 10, 2018 ) The Asia-Pacific Cell Counting Market was worth USD 0.16 billion in 2017 and estimated to be growing at a CAGR of 7.2%, to reach USD 0.22 billion by 2022. Cell counting is used to determine the number of live or dead cells concentration in the cell and also helps in counting of blood cells in the samples. It is used in the medical diagnosis and treatment for quantification of cells in the life sciences. It became an important subset of research areas like cancer biology, neurosciences and immunology with various applications in the clinical practice. Generally, cell counts are expressed as a number of cells per unit of volume within the liquid media.
Cell counting products are being extensively used in the pharmaceutical companies and research institutions with rise in various chronic diseases such as cancer and AIDS. These products help the physician to understand why a patient feels unwell and what to do to help. Nowadays, this process has become an integral part of standard diagnosis in the clinics to determine the full blood count with the help of automated counters to find the concentration of RBCs, WBCs, platelets, and plasma. Cell counting is performed through several methods in which some are primitive and other require some special equipment.
The Asia-Pacific Cell Counting Market is driven by the factors like rising incidences of chronic diseases like cancer and AIDS, demand for cell counting products owing to the growing stem cell research and rise in next-generation technology products, growing awareness of the people in the healthcare sector, increased government policies and funding in the healthcare sector, new product innovations, rise in the advanced healthcare infrastructure and technology advancements in the existing products. However, high cost equipment and lack of proper research infrastructure are hampering the growth of the market.
The Asia-Pacific Cell Counting Market is segmented on the basis of product, end-user and region. On the basis of product, the market is segmented into instruments and consumables. Based on the instruments, the market is segmented into cell counters, hematology analysers, spectrophotometer, flow cytometer, hemocytometer and others. Depending on the consumables, the market is segmented into microplates, reagent and assay kits. On the basis of end-user, the market is segmented into pharmaceutical & biotechnology industries, hospitals & diagnostic laboratories, research & academic institutes and others. In products, the spectrophotometers segment accounted for the largest share of the market due to the enhanced data visualization and analysis software. The Asia-Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia. Asia-Pacific is anticipated to have the fastest growing rate owing to the rising population, investments in this area by the private companies, growing demographics and the emerging economies.
Major companies in the Global Cell Counting Market are Thermo Fisher Scientific, Inc., Danaher Corporation, Agilent Technologies, Bio-Rad Laboratories, Merck Millipore, Inc., GE Healthcare, Becton, Dickinson and Company, and PerkinElmer, Inc.
Market Segmentation:
1) Product
Introduction
Instruments
Consumables
2) End-user
Introduction
Pharmaceutical & Biotechnology Industries
Hospitals & Diagnostic Laboratories
Research & Academic Institutes
Scope of the Report:
Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms Hospitals & Diagnostic along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analyzing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
